Sign up to save your podcasts
Or
Share Uncharted Podcast #94, Democratizing healthcare And The Importance of Continuous Learning With Amy DuRoss, CEO and Co-founder of Vineti
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Uncharted Podcast #94, Democratizing healthcare And The Importance of Continuous Learning With Amy DuRoss, CEO and Co-founder of Vineti
Amy DuRoss, CEO and Co-founder of Vineti, a committed patient advocate, is blazing a trail to orchestrate the supply chain to democratize treatments focused on personalized medicines. This is not her first moon shot to give power to patients.
Before co-founding Vineti, Amy focused on healthcare new business creation for GE Ventures/ healthymagination. Prior to GE, Amy was Chief Business Officer at Navigenics, a genomics company sold to Life Technologies in 2012. She was co-founder and Executive Director of Proposition 71, California’s $3B stem cell research initiative passed in 2004, as well as Chief of Staff at the resulting state grant oversight agency. Amy holds an MBA and MA/BA from Stanford University. She was named a 2016 Health Innovator Fellow by the Aspen Institute.
Connect with Amy DuRoss:
https://www.linkedin.com/in/amy-duross-695b743/
Connect with Robby Allen:
https://www.linkedin.com/in/robbyallen
Connect with Poya Osgouei:
https://www.linkedin.com/in/poyaosgouei/
This week's episode was supported by Oracle NetSuite (sign up for a personalized product tour at www.netsuite.com/scale), Indeed (get a $75 credit for your job post at www.indeed.com/scale) and Bambee (Get your HR Audit for free at Bambee.com/uncharted or Bambee.com/scale)
View all episodes
By Uncharted Podcast
5
3131 ratings
Amy DuRoss, CEO and Co-founder of Vineti, a committed patient advocate, is blazing a trail to orchestrate the supply chain to democratize treatments focused on personalized medicines. This is not her first moon shot to give power to patients.
Before co-founding Vineti, Amy focused on healthcare new business creation for GE Ventures/ healthymagination. Prior to GE, Amy was Chief Business Officer at Navigenics, a genomics company sold to Life Technologies in 2012. She was co-founder and Executive Director of Proposition 71, California’s $3B stem cell research initiative passed in 2004, as well as Chief of Staff at the resulting state grant oversight agency. Amy holds an MBA and MA/BA from Stanford University. She was named a 2016 Health Innovator Fellow by the Aspen Institute.
Connect with Amy DuRoss:
https://www.linkedin.com/in/amy-duross-695b743/
Connect with Robby Allen:
https://www.linkedin.com/in/robbyallen
Connect with Poya Osgouei:
https://www.linkedin.com/in/poyaosgouei/
This week's episode was supported by Oracle NetSuite (sign up for a personalized product tour at www.netsuite.com/scale), Indeed (get a $75 credit for your job post at www.indeed.com/scale) and Bambee (Get your HR Audit for free at Bambee.com/uncharted or Bambee.com/scale)